PureTech Health plc American Depositary Shares (PRTC)
Company News
PureTech Health reported Q2 2025 earnings, highlighting a cash balance of $320 million, reduced operating expenses, and strategic focus on three core spinout entities: Seaport Therapeutics, Gallop Oncology, and Celea Therapeutics.
The pulmonary fibrosis market is driven by the increasing prevalence of the disease, especially idiopathic pulmonary fibrosis, among the aging population. Innovations in drug development and diagnostics, favorable reimbursement policies, and greater awareness are fueling market growth. The pipeline appears robust with over 110 active players work...
PureTech Health (PRTC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199....
Best penny stocks to buy? Biotech penny stocks are heating up & these 4 might be worth watching now. The post Best Penny Stocks To Buy Now? 4 Biotech Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.